• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用抗生物素蛋白-生物素过氧化物酶复合物通过免疫酶染色法观察血管性血友病因子多聚体。

Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex.

作者信息

Aihara M, Sawada Y, Ueno K, Morimoto S, Yoshida Y, de Serres M, Cooper H A, Wagner R H

出版信息

Thromb Haemost. 1986 Apr 30;55(2):263-7.

PMID:3087003
Abstract

A technique for the detection of von Willebrand factor multimers separated by discontinuous SDS agarose electrophoresis has been developed using non-radioactive compounds. The multimeric patterns were visualized by monospecific anti-human vWF:Ag followed by incubation with biotinylated antibody. After addition of avidin-biotin-peroxidase complex, the peroxidase activity was detected by 4-chloro-1-naphthol, giving sharp bands with a clear background. By this method, the differences of vWF:Ag multimers could be easily observed between normal plasma and the plasmas from variant type vWD (IIA, IIB, platelet-type). Large and intermediate multimers were absent in the plasma with vWD type IIA, while only large multimers were absent in the plasma with vWD IIB and platelet-type. The absence of large multimers was also observed in two commercial FVIII preparations having the ratio of vWF/vWF:Ag 0.18 and 0.63. The preparation with the ratio of 0.63 showed the presence of larger intermediate multimers. Electrophoresis in SDS 1.5% agarose gel revealed triplet structure of each small multimer, and a relative increase of the smallest subband was observed in vWD IIA plasma, platelet-type vWD plasma and commercial FVIII preparations. The procedures described are easy and safe to perform and are useful for screening or classifying cases with vWD in general laboratories.

摘要

已开发出一种使用非放射性化合物通过不连续SDS琼脂糖电泳检测血管性血友病因子多聚体的技术。通过单特异性抗人vWF:Ag,随后与生物素化抗体孵育来观察多聚体模式。加入抗生物素蛋白-生物素-过氧化物酶复合物后,用4-氯-1-萘酚检测过氧化物酶活性,可得到背景清晰的清晰条带。通过这种方法,可以很容易地观察到正常血浆与变异型vWD(IIA、IIB、血小板型)血浆之间vWF:Ag多聚体的差异。IIA型vWD血浆中缺乏大的和中等大小的多聚体,而IIB型和血小板型vWD血浆中仅缺乏大的多聚体。在两种vWF/vWF:Ag比率分别为0.18和0.63的市售FVIII制剂中也观察到大的多聚体缺失。比率为0.63的制剂显示存在较大的中等大小的多聚体。在1.5%琼脂糖SDS凝胶中进行电泳显示每个小多聚体的三重结构,并且在IIA型vWD血浆、血小板型vWD血浆和市售FVIII制剂中观察到最小亚带的相对增加。所述程序操作简便且安全,对一般实验室筛查或分类vWD病例很有用。

相似文献

1
Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex.使用抗生物素蛋白-生物素过氧化物酶复合物通过免疫酶染色法观察血管性血友病因子多聚体。
Thromb Haemost. 1986 Apr 30;55(2):263-7.
2
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.1型/2E型(2A亚型IIE)血管性血友病、1型维琴察型血管性血友病以及由血管性血友病因子基因的D3、D4、B1 - B3和C1 - C2结构域突变引起的轻型1型血管性血友病的实验室诊断。血管性血友病因子多聚体及血管性血友病因子前肽/抗原比值的作用。
Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8.
3
Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.遗传性2A型、2B型、2C型、2D型、2E型、2M型、2N型和2U型(无法分类)血管性血友病的分类与特征描述
Clin Appl Thromb Hemost. 2006 Oct;12(4):397-420. doi: 10.1177/1076029606293422.
4
A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.血管性血友病的一种新变体(帕多瓦I型):在所有大小的多聚体存在下,由双重结构组成的血浆血管性血友病因子寡聚体
Haematologia (Budap). 1994;26(2):97-109.
5
Laboratory diagnosis and molecular classification of von Willebrand disease.血管性血友病的实验室诊断与分子分类
Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8.
6
Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.2型诺曼底隐性血管性血友病:轻度血友病和1型血管性血友病的可变表现。
Acta Haematol. 2009;121(2-3):119-27. doi: 10.1159/000214852. Epub 2009 Jun 8.
7
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.1型和2型先天性血管性血友病患者血管性血友病因子参数对去氨加压素的反应:诊断和治疗意义
Semin Thromb Hemost. 2002 Apr;28(2):111-32. doi: 10.1055/s-2002-27814.
8
Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection.采用高分辨率和低分辨率垂直 SDS-琼脂糖凝胶电泳和 Cy5 标记抗体高灵敏度荧光检测同时分析血管性血友病因子多聚体。
Am J Clin Pathol. 2010 Feb;133(2):322-30. doi: 10.1309/AJCPZSBTD2BWOMVL.
9
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.静脉注射去氨加压素和因子VIII-血管性血友病因子浓缩物用于治疗和预防1型、2型和3型血管性血友病患者的出血。
Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399.
10
Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.经典(I型)和变异型(IIA型)血管性血友病亚型中VIII因子/血管性血友病因子的多聚体结构、抗原特性及血浆-血小板含量的异质性异常
J Lab Clin Med. 1983 Mar;101(3):411-25.

引用本文的文献

1
Von Willebrand Factor Multimer Analysis by Low Resolution SDS-Agarose Gel Electrophoresis.低分辨率SDS-琼脂糖凝胶电泳法检测血管性血友病因子多聚体分析
Bio Protoc. 2022 Aug 20;12(16):e4495. doi: 10.21769/BioProtoc.4495.
2
Triplet structure of human von Willebrand factor.人血管性血友病因子的三联体结构
Biochem J. 1998 Apr 15;331 ( Pt 2)(Pt 2):483-8. doi: 10.1042/bj3310483.
3
Analysis of von Willebrand factor multimers using a commercially available enhanced chemiluminescence kit.使用市售增强化学发光试剂盒分析血管性血友病因子多聚体。
J Clin Pathol. 1993 May;46(5):470-3. doi: 10.1136/jcp.46.5.470.
4
Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor.用抗猪血管性血友病因子的鼠单克隆抗体预防闭塞性冠状动脉血栓形成。
Proc Natl Acad Sci U S A. 1987 Nov;84(22):8100-4. doi: 10.1073/pnas.84.22.8100.